Development of novel FLT3 inhibitors for FLT3-positive multiple myeloma cells

被引：0
|
作者：
Yamamoto, Tomofumi [1 ,2 ]
Moriya, Ryohei [3 ,4 ]
Nakayama, Jun [1 ,5 ]
Ochiya, Takahiro [6 ]
Yamamoto, Yusuke [1 ]
机构：
[1] Nat Canc Ctr Res Inst, Lab Integr Oncol, Tokyo, Japan
[2] Tokyo Med Univ, Dept Mol Cell Med, Tokyo, Japan
[3] Tokyo Univ Pharm & Life Sci, Sci Pharm, Tokyo, Japan
[4] Japan Womens Univ, Fac Sci, Tokyo, Japan
[5] JSPS, Tokyo, Japan
[6] Tokyo Med Univ, Dept Mol & Cellular Med, Tokyo, Japan
来源：
CANCER SCIENCE | 2023年 / 114卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
J-2017
引用
收藏
页码：833 / 833
页数：1
相关论文
共 50 条
  • [41] Discovery and Characterization of Novel Mutant FLT3 Kinase Inhibitors
    Weisberg, Ellen
    Choi, Hwan Geun
    Barrett, Rosemary
    Zhou, Wenjun
    Zhang, Jianming
    Ray, Arghya
    Nelson, Erik A.
    Jiang, Jingrui
    Moreno, Daisy
    Stone, Richard
    Galinsky, Ilene
    Fox, Edward
    Adamia, Sophia
    Kung, Andrew L.
    Gray, Nathanael S.
    Griffin, James D.
    MOLECULAR CANCER THERAPEUTICS, 2010, 9 (09) : 2468 - 2477
  • [42] Overcoming Resistance to FLT3 Inhibitors in the Treatment of FLT3-Mutated AML
    Lam, Stephen S. Y.
    Leung, Anskar Y. H.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (04)
  • [43] The clinical development of FLT3 inhibitors in acute myeloid leukemia
    Knapper, Steven
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2011, 20 (10) : 1377 - 1395
  • [44] HM43239, a novel FLT3 inhibitor, has the potential to inhibit mutations resistant to FLT3 inhibitors.
    Bae, Inhwan
    Choi, Jaeyul
    Song, Jiyoung
    Byun, Joo-Yun
    Lee, Eunyoung
    Song, Taehun
    Kim, Yu-Yon
    Bak, Yesol
    Kim, Young Hoon
    Ahn, Young Gil
    Suh, Kwee Hyun
    CANCER RESEARCH, 2021, 81 (13)
  • [45] FLT3 inhibitors and hematopoietic cell transplantation prolong survival in patients with FLT3-ITD-positive AML
    Matsukawa, Toshihiro
    Onozawa, Masahiro
    Kondo, Takeshi
    Kanaya, Minoru
    Hidaka, Daisuke
    Ota, Shuichi
    Mori, Akio
    Shigematsu, Akio
    Miyagishima, Takuto
    Kakinoki, Yasutaka
    Hashiguchi, Junichi
    Yamamoto, Satoshi
    Yamamoto, Masayo
    Wakasa, Kentaro
    Takahata, Mutsumi
    Ishihara, Toshimichi
    Haseyama, Yoshihito
    Fujimi, Akihito
    Igarashi, Tetsuya
    Sarashina, Takehiro
    Iyama, Satoshi
    Kobayashi, Ryoji
    Sakai, Hajime
    Fujimoto, Katsuya
    Inamura, Junki
    Kanisawa, Yuji
    Hirabayashi, Shinsuke
    Endo, Tomoyuki
    Hashimoto, Daigo
    Teshima, Takanori
    ANNALS OF HEMATOLOGY, 2024, : 5333 - 5340
  • [46] The Immunomodulatory Effect of Different FLT3 Inhibitors on Dendritic Cells
    Schlaweck, Sebastian
    Radcke, Alea
    Kampmann, Sascha
    Becker, Benjamin V.
    Brossart, Peter
    Heine, Annkristin
    CANCERS, 2024, 16 (21)
  • [47] Understanding and overcoming FLT3 ligand-mediated Resistance to Type II FLT3 Inhibitors
    Alqahtani, Taha
    MacEwan, David
    BRITISH JOURNAL OF PHARMACOLOGY, 2021, 178 (02) : 406 - 406
  • [48] Resistance to Selective FLT3 Inhibitors, Driven by FLT3 Ligand and FLT3 Point Mutations, Can Be Overcome with the Dual FLT3-Aurora Kinase Inhibitor CCT241736
    Moore, Andrew S.
    Faisal, Amir
    Bavetsias, Vassilios
    de Castro, David Gonzalez
    Sun, Chongbo
    Atrash, Butrus
    Valenti, Melanie
    Brandon, Alexis de Haven
    Avery, Sian
    Pearson, Andrew D. J.
    Workman, Paul
    Blagg, Julian
    Raynaud, Florence I.
    Eccles, Suzanne A.
    Linardopoulos, Spiros
    BLOOD, 2011, 118 (21) : 1490 - 1490
  • [49] A novel FLT3 inhibitor FI-700 selectively suppresses the growth of leukemia cells with FLT3 mutations
    Kiyoi, Hitoshi
    Shiotsu, Yukimasa
    Ozeki, Kazutaka
    Yamaji, Satomi
    Kosugi, Hiroshi
    Umehara, Hiroshi
    Shimizu, Makiko
    Arai, Hitoshi
    Ishii, Kenichi
    Akinaga, Shiro
    Naoe, Tomoki
    CLINICAL CANCER RESEARCH, 2007, 13 (15) : 4575 - 4582
  • [50] Characterization of dual resistant AML cells to FLT3 inhibitors
    Katayama, Kazuhiro
    CANCER SCIENCE, 2023, 114 : 1482 - 1482
12345